| Literature DB >> 16809779 |
Toshiyuki Sakamaki1, Mathew C Casimiro, Xiaoming Ju, Andrew A Quong, Sanjay Katiyar, Manran Liu, Xuanmao Jiao, Anping Li, Xueping Zhang, Yinan Lu, Chenguang Wang, Stephen Byers, Robert Nicholson, Todd Link, Melvin Shemluck, Jianguo Yang, Stanley T Fricke, Phyllis M Novikoff, Alexandros Papanikolaou, Andrew Arnold, Christopher Albanese, Richard Pestell.
Abstract
The cyclin D1 gene encodes a regulatory subunit of the holoenzyme that phosphorylates and inactivates the pRb tumor suppressor to promote nuclear DNA synthesis. cyclin D1 is overexpressed in human breast cancers and is sufficient for the development of murine mammary tumors. Herein, cyclin D1 is shown to perform a novel function, inhibiting mitochondrial function and size. Mitochondrial activity was enhanced by genetic deletion or antisense or small interfering RNA to cyclin D1. Global gene expression profiling and functional analysis of mammary epithelial cell-targeted cyclin D1 antisense transgenics demonstrated that cyclin D1 inhibits mitochondrial activity and aerobic glycolysis in vivo. Reciprocal regulation of these genes was observed in cyclin D1-induced mammary tumors. Cyclin D1 thus integrates nuclear DNA synthesis and mitochondrial function.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16809779 PMCID: PMC1592725 DOI: 10.1128/MCB.02074-05
Source DB: PubMed Journal: Mol Cell Biol ISSN: 0270-7306 Impact factor: 4.272